Association between hypnotics use and increased mortality: Causation or confounding?

European Journal of Clinical Pharmacology

Volumn 71, Issue 5, 2015, Pages 637-642

  Neutel, C Ineke ^a   Johansen, Helen L ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Benzodiazepines; Causation; Confounding; Hypnotics; Mortality; Terminal illness; z Hypnotics

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

ADULT; AGED; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EPIDEMIOLOGY; HUMAN; MIDDLE AGED; MORTALITY; NORWAY; STATISTICS AND NUMERICAL DATA; TERMINALLY ILL PATIENT; TRENDS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BENZODIAZEPINES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; HYPNOTICS AND SEDATIVES; MIDDLE AGED; MORTALITY; NORWAY; TERMINALLY ILL;

EID: 84937764112     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-015-1841-z     Document Type: Article

References (29)

1. Kripke DF, Langer RD, Kline LE (2012) Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open 2(1):e000850
2. Mallon L, Broman JE, Hetta J (2009) Is usage of hypnotics associated with mortality? Sleep Med 10(3):279-286
3. Belleville G (2010) Mortality hazard associated with anxiolytic and hypnotic drug use in the National Population Health Survey. Can J Psychiatry 55(9):558-567
4. Hausken AM, Skurtveit S, Tverdal A (2007) Use of anxiolytic or hypnotic drugs and total mortality in a general middle-aged population. Pharmacoepidemiol Drug Saf 16(8):913-918
5. Mallon L, Broman JE, Hetta J (2002) Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population. J Intern Med 251(3):207-216
6. Merlo J et al (1996) Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics. Results of the 10-year follow-up of the prospective population study "Men born in 1914", Malmo, Sweden. Eur J Clin Pharmacol 49(4):261-265
7. Fukuhara S et al (2006) Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan. Kidney Int 70(10):1866-1872
8. Weich S et al (2014) Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ 348:g1996
9. Kripke DF (2009) Do hypnotics cause death and cancer? The burden of proof. Sleep Med 10(3):275-276
10. Phillips B, Mannino DM (2005) Does insomnia kill? Sleep 28(8):965-971
11. Ahmad R, Bath PA (2005) Identification of risk factors for 15-year mortality among community-dwelling older people using Cox regression and a genetic algorithm. J Gerontol A Biol Sci Med Sci 60(8):1052-1058
12. Jaussent I et al (2013) Hypnotics and mortality in an elderly general population: a 12-year prospective study. BMC Med 11:212
13. Kripke DF, Langer RD, Kline LE (2012) Do no harm: not even to some degree. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med 8(4):353-354
14. Furu K (2001) Drug utilisation in a public health perspective: Establishing a national prescription register in Norway. Nor J Epidemiol 11:55-60
15. Furu K et al (2010) The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106(2):86-94
16. WHO, Collaborating Centre for Drugs Statistics Methodology: ATC/DDD Index 2011: Oslo, Norway, available from: http://www.whocc.no last accessed 10/05/2013
17. Fahlman C et al (2006) Prescription drug spending for Medicare + Choice beneficiaries in the last year of life. J Palliat Med 9(4):884-893
18. Langton JM (2013) Prescription drug use in the last 12 months of life: observations in a cohort of elderly patients, in International Conference of Pharmacoepidemiology. Pharmacoepidemiol Drug Saf Montr. Abstract 703
19. Chen HC, Su TP, Chou P (2013) A nine-year follow-up study of sleep patterns and mortality in community-dwelling older adults in Taiwan. Sleep 36(8):1187-1198
20. Hays JC, Blazer DG, Foley DJ (1996) Risk of napping: excessive daytime sleepiness and mortality in an older community population. J Am Geriatr Soc 44(6):693-698
21. Kojima M et al (2000) Sleep patterns and total mortality: a 12-year follow-up study in Japan. J Epidemiol 10(2):87-93
22. Coleman MP et al (2008) Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 9(8):730-756
23. Verdecchia A et al (2008) Patient survival for all cancers combined as indicator of cancer control in Europe. Eur J Public Health 18(5):527-532
24. Brelin S et al (2013) Antidepressants to cancer patients during the last year of life - population-based study. Psychooncology 22(3):506-514
25. Wang PS et al (2005) Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 353(22):2335-2341
26. Strom B (2005) Pharmacoepidemiology. John Wiley & Sons Ltd., Chichester
27. Pottegard A et al (2013) Use of benzodiazepines or benzodiazepine related drugs and the risk of cancer: a population-based case-control study. Br J Clin Pharmacol 75(5):1356-1364
28. Kao CH et al (2012) Relationship of zolpidem and cancer risk: a Taiwanese population-based cohort study. Mayo Clin Proc 87(5):430-436
29. Kripke DF (2007) Greater incidence of depression with hypnotic use than with placebo. BMC Psychiatry 7:42